Coverage Initiated on Immunotherapy Developer with Phase 3 Lead Asset

Research Report
  ()
A B. Riley FBR report provided an overview of this life sciences firm. read more >

Transfusion Medicine Biotech Hits Target on Road to Commercialization

Research Report
  ()
A BTIG report reviewed the news announced by this supplier of blood grouping reagents and control products. read more >

Agreement Facilitates Progress Toward Medical Device Approvals

  ()
This medical device company enters a partnership to provide quality and regulatory services. read more >
News Update

Biotech Targeting Alzheimer's Disease Advances Toward Phase 1

  ()
Having secured a manufacturing partner for its proprietary antibody candidate, this precision medicine company charts progress toward a Phase 1 trial in Alzheimer's disease. read more >

Biotech Releases 'Unequivocally Positive' Topline NASH Study Results

Research Report
  ()
An H.C. Wainwright & Co. report relayed the highlights of the new trial data from this Israel-based firm. read more >

Mobile Health Platform Firm Signs Deal That Will Increase Pace of Onboarding Patients

  ()
A technology company that develops mobile health and telemedicine platforms for community-based healthcare has raised money, made a deal that will accelerate the number of patients it adds every month, and is breaking through its hardware logjam. read more >

Biotech Consolidates Shares in Preparation for NASDAQ Listing

Research Report
  ()
A Canaccord Genuity analyst provided an update on this late-stage Canadian life sciences firm targeting metastatic breast cancer. read more >

Coverage Initiated on Developer of Women's Reproductive Health Products

Research Report
  ()
A ROTH Capital Partners research report outlined the key drivers of the investment thesis for this firm. read more >

Analyst: 'New CEO, Larger Sales Team and Greater SUI Focus Should Help Medical Device Growth'

Research Report
  ()
Cowen analyst Dr. Joshua Jennings highlighted this medical device firm’s Q1/18 developments and financial results. read more >

Biotech Announces Encouraging HIV Vaccine Results

Research Report
  ()
Ram Selvaraju, an analyst with H.C. Wainwright & Co., explained the recently released data from a study of one of this immunotherapy firm's therapeutics. read more >
Expert Investing Ideas

"DRRX reported its Q1/18, mostly in line with expectations."

–Francois Brisebois, Laidlaw & Company


"PMN is seeking to forge partnerships with big pharmas."

–André Uddin, Mackie Research Capital


"We believe 2018 could prove to be a pivotal year for DRRX."

–Francois Brisebois, Laidlaw & Company


"We continue to be positive about DRRX's story."

–Grant Zeng, Zacks Small-Cap Research


"DRRX is now highly attractive as a potential speculative play."

–Terry Chrisomalis, Biotech Analysis Central


Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical

Shovelnose Delivers Gold to Westhaven

Contributed Opinion
  ()
Bob Moriarty of 321 Gold profiles a company that holds a large land position in the "most unexplored gold belt in British Columbia." read more >
Management Q&A: View from the Top

Cancer in the Crosshairs: IMV Looks to Deliver Immunotherapy a New Way

Managment Q&A: View from the Top
  ()
In this interview with The Life Sciences Report, IMV Inc.'s CEO Fred Ors and Pierre Labbè, chief financial officer, describe the innovative immunotherapy platform technology that has attracted partnerships with big pharma, prompted reorganization of the company, and holds long-term promise for cancer patients. read more >

Biotech's Launch of Pain Product Shows Encouraging Early Metrics

Research Report
  ()
Francois Brisebois, an analyst with Laidlaw & Co., reviewed this firm's progress since commercially debuting its primary asset. read more >

Cell Therapy Firm Finalizing $5.1M Strategic Investment and Partnership with Chinese Company

  ()
The terms of a proposed agreement between this cell therapy company and YOFOTO, a Chinese health and consumer products company, have been revised and will result in a $5.1 million investment. read more >